Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1119]

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy

Bridge therapy may benefit some children with high-risk neuroblastoma

Bridge therapy may benefit some children with high-risk neuroblastoma

ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

ASCO 2022: Dabrafenib plus trametinib significantly increases overall response rate in paediatric low-grade gliomas

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

ASCO 2022: ASCO & WHO to collaborate on quality indicators for cancer facilities worldwide

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Exploiting a vulnerability in an aggressive leukaemia affecting babies

Molecular profiling identifies new high-risk subtype of paediatric liver cancer

Molecular profiling identifies new high-risk subtype of paediatric liver cancer

Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours

Tumours on withdrawal: Amino acid deficiency shrinks childhood tumours

Scientists identify new molecular strategies for tackling aggressive form of leukaemia

Scientists identify new molecular strategies for tackling aggressive form of leukaemia

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared to non-Latino white children

AACR 2022: Some Latino children diagnosed with acute lymphoblastic leukaemia face higher risk of relapse compared...

AACR 2022: Paediatric cancer patients in lower-and middle-income countries faced significantly higher mortality risk during the COVID-19 pandemic

AACR 2022: Paediatric cancer patients in lower-and middle-income countries faced significantly higher mortality...

More from ecancer